Skip to main content

Table 2 Variation in prescribing rates by primary care trust (PCT)

From: Exploring the equity of GP practice prescribing rates for selected coronary heart disease drugs: a multiple regression analysis with proxies of healthcare need

Drug group

 

PCT1

PCT2

PCT3

PCT4

Statins

Min

11.05

9.56

6.86

6.44

 

Max

47.23

32.12

46.60

45.76

 

Median

22.88

19.65

18.08

17.36

 

IQR

8.20

11.20

8.40

7.24

Aspirin

Min

14.62

15.34

4.94

9.6

 

Max

44.97

46.40

46.63

45.65

 

Median

29.27

27.35

25.33

30.87

 

IQR

7.40

16.5

7.60

18.85

Beta-blockers

Min

5.04

6.38

3.94

3.43

 

Max

23.92

29.04

23.91

26.19

 

Median

12.84

12.38

12.32

12.64

 

IQR

4.61

7.70

7.41

10.11

ACE inhibitors

Min

15.47

9.85

4.20

4.69

 

Max

48.40

39.25

32.97

35.69

 

Median

26.43

19.76

16.59

19.19

 

IQR

8.82

11.17

9.37

11.29

Bendrofluazide

Min

4.19

1.63

1.63

0.60

 

Max

35.61

29.55

32.90

22.91

 

Median

14.42

10.85

11.04

9.01

 

IQR

6.98

8.15

12.70

7.28

All study CHD drugs

Min

71.70

57.28

25.89

24.76

 

Max

156.82

154.21

136.64

150.68

 

Median

105.37

92.78

90.33

83.65

 

IQR

28.25

57.07

32.08

51.18